GO
Loading...

'Cautiously optimistic' over Pfizer-AstraZeneca deal: Pro

Thursday, 8 May 2014 | 7:00 PM ET

Mark Artus, CEO of 1HQ, discusses the implications behind the possible acquisition of Pfizer by AstraZeneca.